Correlation Between Boston Beer and NervGen Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Boston Beer and NervGen Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Boston Beer and NervGen Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Boston Beer and NervGen Pharma Corp, you can compare the effects of market volatilities on Boston Beer and NervGen Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Boston Beer with a short position of NervGen Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Boston Beer and NervGen Pharma.

Diversification Opportunities for Boston Beer and NervGen Pharma

-0.36
  Correlation Coefficient

Very good diversification

The 3 months correlation between Boston and NervGen is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Boston Beer and NervGen Pharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NervGen Pharma Corp and Boston Beer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Boston Beer are associated (or correlated) with NervGen Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NervGen Pharma Corp has no effect on the direction of Boston Beer i.e., Boston Beer and NervGen Pharma go up and down completely randomly.

Pair Corralation between Boston Beer and NervGen Pharma

Considering the 90-day investment horizon Boston Beer is expected to generate 8.52 times less return on investment than NervGen Pharma. But when comparing it to its historical volatility, Boston Beer is 2.91 times less risky than NervGen Pharma. It trades about 0.03 of its potential returns per unit of risk. NervGen Pharma Corp is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  140.00  in NervGen Pharma Corp on September 1, 2024 and sell it today you would earn a total of  63.00  from holding NervGen Pharma Corp or generate 45.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Boston Beer  vs.  NervGen Pharma Corp

 Performance 
       Timeline  
Boston Beer 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Boston Beer are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, Boston Beer displayed solid returns over the last few months and may actually be approaching a breakup point.
NervGen Pharma Corp 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in NervGen Pharma Corp are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly unfluctuating basic indicators, NervGen Pharma may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Boston Beer and NervGen Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Boston Beer and NervGen Pharma

The main advantage of trading using opposite Boston Beer and NervGen Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Boston Beer position performs unexpectedly, NervGen Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NervGen Pharma will offset losses from the drop in NervGen Pharma's long position.
The idea behind Boston Beer and NervGen Pharma Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio